DTcP-Hib-MCV4 Combined Vaccine
Diphtheria, Tetanus, Pertussis, Hib, Meningococcal Prevention
Phase 1Active
Key Facts
Indication
Diphtheria, Tetanus, Pertussis, Hib, Meningococcal Prevention
Phase
Phase 1
Status
Active
Company
About CanSino Biologics
A leading Chinese vaccine developer leveraging adenovirus vector technology to create innovative vaccines for global infectious disease prevention.
View full company profile